Venglustat-based solutions for industrial applications

Publication ID: 24-11857512_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Venglustat-based solutions for industrial applications,” Published Technical Disclosure No. 24-11857512_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857512_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,512.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of venglustat to address unmet needs in wastewater treatment, food preservation, wood protection, corrosion prevention, and algae control, thereby expanding its industrial applicability beyond pharmaceuticals.

Background and Problem Solved

The original patent disclosed pharmaceutical compositions comprising venglustat for treating diseases. However, the potential of venglustat as a broad-spectrum inhibitor of microorganisms was underutilized. The present inventive concept addresses this limitation by applying venglustat to novel industrial applications, capitalizing on its ability to inhibit microbial growth.

Detailed Description of the Inventive Concept

The inventive concept encompasses various systems and methods utilizing venglustat to tackle industrial challenges. In wastewater treatment, venglustat inhibits microorganisms that degrade infrastructure. In food preservation, venglustat prevents spoilage by inhibiting microbial growth. For wood protection, venglustat is applied to prevent fungal decay. In corrosion prevention, venglustat inhibits microorganisms that contribute to metal surface corrosion. Finally, in algae control, venglustat is used to inhibit algae growth in aquatic systems. These applications capitalize on venglustat's unique properties, offering novel solutions for pressing industrial problems.

Novelty and Inventive Step

The inventive concept's novelty lies in its application of venglustat to entirely new industries, leveraging its microbial inhibition properties to address unmet needs. The inventive step resides in recognizing venglustat's potential beyond pharmaceuticals and adapting its use to solve distinct industrial challenges.

Alternative Embodiments and Variations

Alternative embodiments may include using venglustat in combination with other agents or technologies to enhance its effectiveness. Variations may involve modifying venglustat's formulation or delivery methods to suit specific industrial applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including wastewater treatment, food processing, wood preservation, corrosion protection, and algae control. The market for these applications is substantial, with opportunities for partnerships, licensing, and product development.

CPC Classifications

SectionClassGroup
A A61 A61K31/439
A A61 A61K9/0053
A A61 A61K9/2009
A A61 A61K9/2013
A A61 A61K9/2018
A A61 A61K9/2095
A A61 A61K9/485
A A61 A61K9/4833
A A61 A61K9/4858
A A61 A61K9/4866

Field of Art

Pharmaceutical and industrial chemical engineering, with expertise in compound formulation, microbial inhibition technologies, and chemical applications across pharmaceutical and industrial domains

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in chemistry or chemical engineering, familiar with compound modification, microbial interaction mechanisms, and cross-domain application of chemical compounds

Obviousness Rationale

A PHOSITA would recognize venglustat's microbial inhibition properties as inherently transferable across different technical domains. The source patent establishes venglustat's core mechanism of enzyme inhibition, which naturally suggests potential applications beyond pharmaceutical uses. The PTD's industrial variations represent predictable extensions of the compound's fundamental biochemical characteristics.

Obvious Combinations & Variations

Source Patent Element
Venglustat as a quinuclidine compound with enzyme inhibition properties
PTD Variation
Application of venglustat for microbial growth inhibition in wastewater treatment
Obviousness Reasoning
A PHOSITA would recognize that enzyme inhibition mechanisms can be directly applied to controlling microorganism proliferation across different environmental contexts
Source Patent Element
Pharmaceutical formulation techniques for venglustat
PTD Variation
Adapting venglustat delivery methods for wood protection and corrosion prevention
Obviousness Reasoning
Formulation techniques are readily transferable between pharmaceutical and industrial applications, representing a known technique for compound adaptation
Source Patent Element
Venglustat's chemical structure enabling targeted biological interactions
PTD Variation
Using venglustat to control algae growth in aquatic systems
Obviousness Reasoning
A PHOSITA would understand that compounds with specific biological interaction capabilities can be predictably applied to related inhibition challenges
Source Patent Element
Pharmaceutical composition methods involving compound modification
PTD Variation
Combining venglustat with additional agents to enhance industrial application effectiveness
Obviousness Reasoning
Combination of active compounds is a standard technique in chemical engineering for improving performance across various domains
Source Patent Element
Venglustat's demonstrated ability to interact with biological systems
PTD Variation
Food preservation applications using microbial growth inhibition
Obviousness Reasoning
Extending antimicrobial properties to food preservation represents a predictable and logical application of the compound's inherent characteristics
35 U.S.C. § 103 Summary: Based on US Patent 11857512's disclosure of venglustat's fundamental chemical properties, the present publication demonstrates that a person of ordinary skill in the art would find the industrial applications of venglustat obvious and predictable, thereby establishing prior art that would render subsequent claims of novel industrial applications non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,512
TitlePharmaceutical compositions comprising venglustat
Assignee(s)Genzyme Corporation